Portfolio Holdings Detail for ISIN IE000R9FA4A0
Stock Name / Fund iShares S&P 500 ESG UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares III Public Limited Company
Entity Type
Entity LEI 549300PZLRJB7M8H1057
ETF Ticker ESPX(USD) AS
ETF Ticker ESPX(USD) Euronext Amsterdam

Holdings detail for EW

Stock Name	Edwards Lifesciences Corp
Ticker	EW(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US28176E1082
LEI	YA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen: Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings: Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab: Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW): Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research: Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen: Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00: Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00: Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price: Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism: The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks: The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW): J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW): Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC: Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW): Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares S&P 500 ESG UCITS ETF USD (Acc) EW holdings

Date	Number of EW Shares Held	Base Market Value of EW Shares	Local Market Value of EW Shares	Change in EW Shares Held	Change in EW Base Value	Current Price per EW Share Held	Previous Price per EW Share Held
2025-09-25 (Thursday)	11,037	USD 830,755	USD 830,755	0	USD 6,733	USD 75.27	USD 74.66
2025-09-24 (Wednesday)	11,037	USD 824,022	USD 824,022
2025-09-18 (Thursday)	10,670	USD 795,449	USD 795,449	0	USD -6,935	USD 74.55	USD 75.2
2025-09-17 (Wednesday)	10,670	USD 802,384	USD 802,384	0	USD 1,174	USD 75.2	USD 75.09
2025-09-16 (Tuesday)	10,670	USD 801,210	USD 801,210	-159	USD -22,335	USD 75.09	USD 76.05
2025-09-15 (Monday)	10,829	USD 823,545	USD 823,545	0	USD -16,461	USD 76.05	USD 77.57
2025-09-12 (Friday)	10,829	USD 840,006	USD 840,006	0	USD -4,764	USD 77.57	USD 78.01
2025-09-11 (Thursday)	10,829	USD 844,770	USD 844,770	-156	USD -15,136	USD 78.01	USD 78.28
2025-09-10 (Wednesday)	10,985	USD 859,906	USD 859,906
2025-09-09 (Tuesday)	10,985	USD 876,603	USD 876,603

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE000R9FA4A0

Show aggregate share trades of EW

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-16 SELL -159 75.090* 73.43 Profit of 11,675 on sale
2025-09-11 SELL -156 78.010* 73.36 Profit of 11,445 on sale
2025-08-29 BUY 207 81.340* 73.32
2025-08-06 BUY 51 78.610* 73.21
2025-07-31 BUY 310 79.310* 73.10
2025-07-22 BUY 51 76.300* 72.86
2025-07-14 SELL -51 78.280* 72.71 Profit of 3,708 on sale
2025-07-02 BUY 52 77.020* 72.46
2025-06-30 BUY 144 78.210* 72.42
2025-06-27 BUY 270 78.210* 72.38
2025-06-26 BUY 102 77.150* 72.35
2025-06-18 SELL -51 73.980* 72.23 Profit of 3,684 on sale
2025-06-17 SELL -255 73.270* 72.22 Profit of 18,416 on sale
2025-06-13 BUY 371 75.150* 72.18
2025-06-05 BUY 51 77.770* 71.97
2025-05-30 BUY 306 78.220* 71.78
2025-05-22 SELL -102 74.790* 71.59 Profit of 7,303 on sale
2025-05-19 BUY 510 78.040* 71.44
2025-05-16 BUY 47 78.000* 71.38
2025-05-14 BUY 50 76.750* 71.29
2025-05-01 SELL -50 75.180* 70.96 Profit of 3,548 on sale
2025-04-23 BUY 150 70.460* 70.72
2025-04-17 BUY 50 71.530* 70.72
2025-04-11 BUY 52 69.400* 70.74
2025-04-07 SELL -357 69.000* 70.85 Profit of 25,292 on sale
2025-04-04 SELL -459 69.360* 70.86 Profit of 32,527 on sale
2025-03-21 BUY 316 70.460* 70.80
2025-03-18 SELL -200 70.340* 70.80 Profit of 14,160 on sale
2025-03-17 SELL -488 70.630* 70.80 Profit of 34,552 on sale
2025-03-13 SELL -100 67.950* 70.87 Profit of 7,087 on sale
2025-03-10 SELL -51 68.530* 70.98 Profit of 3,620 on sale
2025-03-05 SELL -153 72.850* 70.95 Profit of 10,855 on sale
2025-03-03 SELL -51 71.390* 70.93 Profit of 3,617 on sale
2025-02-21 SELL -192 73.300* 70.80 Profit of 13,594 on sale
2025-02-14 SELL -204 76.190* 70.33 Profit of 14,346 on sale
2025-02-12 SELL -255 75.820* 70.09 Profit of 17,872 on sale
2025-02-10 BUY 51 71.100* 70.05
2025-02-05 BUY 705 72.100* 69.97
2025-02-03 BUY 102 71.380* 69.90
2025-01-31 BUY 450 72.450* 69.83
2025-01-29 BUY 255 71.130* 69.71
2025-01-28 BUY 49 72.560* 69.63
2025-01-24 BUY 51 68.990* 69.66
2024-12-09 BUY 49 70.900* 69.52
2024-12-06 BUY 676 71.530* 69.46
2024-12-03 BUY 208 70.200* 69.14
2024-12-02 BUY 52 70.530* 69.09
2024-11-29 BUY 46 71.350* 69.00
2024-11-08 BUY 357 66.230* 68.25
2024-10-31 BUY 47 67.010* 69.52
2024-10-30 BUY 50 68.630* 69.65
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-16	SELL	-159	75.090*	73.43 Profit of 11,675 on sale
2025-09-11	SELL	-156	78.010*	73.36 Profit of 11,445 on sale
2025-08-29	BUY	207	81.340*	73.32
2025-08-06	BUY	51	78.610*	73.21
2025-07-31	BUY	310	79.310*	73.10
2025-07-22	BUY	51	76.300*	72.86
2025-07-14	SELL	-51	78.280*	72.71 Profit of 3,708 on sale
2025-07-02	BUY	52	77.020*	72.46
2025-06-30	BUY	144	78.210*	72.42
2025-06-27	BUY	270	78.210*	72.38
2025-06-26	BUY	102	77.150*	72.35
2025-06-18	SELL	-51	73.980*	72.23 Profit of 3,684 on sale
2025-06-17	SELL	-255	73.270*	72.22 Profit of 18,416 on sale
2025-06-13	BUY	371	75.150*	72.18
2025-06-05	BUY	51	77.770*	71.97
2025-05-30	BUY	306	78.220*	71.78
2025-05-22	SELL	-102	74.790*	71.59 Profit of 7,303 on sale
2025-05-19	BUY	510	78.040*	71.44
2025-05-16	BUY	47	78.000*	71.38
2025-05-14	BUY	50	76.750*	71.29
2025-05-01	SELL	-50	75.180*	70.96 Profit of 3,548 on sale
2025-04-23	BUY	150	70.460*	70.72
2025-04-17	BUY	50	71.530*	70.72
2025-04-11	BUY	52	69.400*	70.74
2025-04-07	SELL	-357	69.000*	70.85 Profit of 25,292 on sale
2025-04-04	SELL	-459	69.360*	70.86 Profit of 32,527 on sale
2025-03-21	BUY	316	70.460*	70.80
2025-03-18	SELL	-200	70.340*	70.80 Profit of 14,160 on sale
2025-03-17	SELL	-488	70.630*	70.80 Profit of 34,552 on sale
2025-03-13	SELL	-100	67.950*	70.87 Profit of 7,087 on sale
2025-03-10	SELL	-51	68.530*	70.98 Profit of 3,620 on sale
2025-03-05	SELL	-153	72.850*	70.95 Profit of 10,855 on sale
2025-03-03	SELL	-51	71.390*	70.93 Profit of 3,617 on sale
2025-02-21	SELL	-192	73.300*	70.80 Profit of 13,594 on sale
2025-02-14	SELL	-204	76.190*	70.33 Profit of 14,346 on sale
2025-02-12	SELL	-255	75.820*	70.09 Profit of 17,872 on sale
2025-02-10	BUY	51	71.100*	70.05
2025-02-05	BUY	705	72.100*	69.97
2025-02-03	BUY	102	71.380*	69.90
2025-01-31	BUY	450	72.450*	69.83
2025-01-29	BUY	255	71.130*	69.71
2025-01-28	BUY	49	72.560*	69.63
2025-01-24	BUY	51	68.990*	69.66
2024-12-09	BUY	49	70.900*	69.52
2024-12-06	BUY	676	71.530*	69.46
2024-12-03	BUY	208	70.200*	69.14
2024-12-02	BUY	52	70.530*	69.09
2024-11-29	BUY	46	71.350*	69.00
2024-11-08	BUY	357	66.230*	68.25
2024-10-31	BUY	47	67.010*	69.52
2024-10-30	BUY	50	68.630*	69.65

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	406,402	0	1,881,727	21.6%
2025-09-18	684,520	1,177	3,487,981	19.6%
2025-09-17	484,322	210	1,603,065	30.2%
2025-09-16	811,953	856	2,055,937	39.5%
2025-09-15	611,012	104	1,391,882	43.9%
2025-09-12	982,928	1,100	2,234,227	44.0%
2025-09-11	514,234	828	1,919,009	26.8%
2025-09-10	669,705	149	1,567,941	42.7%
2025-09-09	441,493	0	925,375	47.7%
2025-09-08	632,587	672	1,251,939	50.5%
2025-09-05	334,037	300	934,006	35.8%
2025-09-04	380,318	0	871,931	43.6%
2025-09-03	701,943	459	1,170,966	59.9%
2025-09-02	397,396	53	1,208,872	32.9%
2025-08-29	397,628	800	844,318	47.1%
2025-08-28	604,087	4	1,056,653	57.2%
2025-08-27	493,608	822	875,886	56.4%
2025-08-26	480,268	0	868,213	55.3%
2025-08-25	796,556	0	1,181,258	67.4%
2025-08-22	552,739	1	1,011,678	54.6%
2025-08-21	873,044	798	1,597,742	54.6%
2025-08-20	847,847	38,699	1,560,105	54.3%
2025-08-19	613,349	33	1,256,577	48.8%
2025-08-18	668,719	439	1,642,759	40.7%
2025-08-15	369,455	513	826,723	44.7%
2025-08-14	514,202	6,112	864,593	59.5%
2025-08-13	567,857	299	1,347,264	42.1%
2025-08-12	547,773	12,316	1,428,277	38.4%
2025-08-11	487,823	0	1,152,630	42.3%
2025-08-08	661,697	20	1,224,458	54.0%
2025-08-07	669,931	982	1,297,469	51.6%
2025-08-06	880,028	413	1,551,659	56.7%
2025-08-05	661,933	8	1,592,649	41.6%
2025-08-04	572,165	268	1,310,044	43.7%
2025-08-01	678,028	5,600	1,308,863	51.8%
2025-07-31	831,401	249	1,817,975	45.7%
2025-07-30	1,305,016	693	2,481,808	52.6%
2025-07-29	1,129,154	58	2,399,223	47.1%
2025-07-28	684,101	2,111	2,276,892	30.0%
2025-07-25	1,669,752	920	6,616,259	25.2%
2025-07-24	455,593	0	2,607,898	17.5%
2025-07-23	444,645	0	1,978,110	22.5%
2025-07-22	447,883	511	2,702,925	16.6%
2025-07-21	568,293	27	1,249,727	45.5%
2025-07-18	590,448	59	2,118,402	27.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares S&P 500 ESG UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares III Public Limited Company
Entity Type
Entity LEI	549300PZLRJB7M8H1057
ETF Ticker	ESPX(USD) AS
ETF Ticker	ESPX(USD) Euronext Amsterdam